Patient-reported rating of gastrointestinal adverse effects during treatment of type 2 diabetes with the once-daily human GLP-1 analogue, liraglutide

M Horowitz, Tina Vilsbøll, M Zdravkovic, M Hammer, S Madsbad

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

25 Citationer (Scopus)

Abstract

Udgivelsesdato: 2008/7
OriginalsprogEngelsk
TidsskriftDiabetes, Obesity and Metabolism
Vol/bind10
Udgave nummer7
Sider (fra-til)593-6
Antal sider4
ISSN1462-8902
DOI
StatusUdgivet - 1 jul. 2008

Citationsformater